Tom Plasterer, PhD, Senior Director, Bioinformatics, BioPharmaceutical R&D, AstraZeneca—Dr. Plasterer has pursued interests in bioinformatics, clinical informatics, systems biology and biomarker discovery over the last twenty years in both industry and academia. He co-founded PanGenX (a Personalized Medicine/Pharmacogenetics Knowledge Base start-up), directed the project planning and data interpretation group at BG Medicine, and held an adjunct professor position in the department of Chemistry and Chemical Biology at Northeastern University. He now leads translational science data integration and FAIR data initiatives at AstraZeneca. In these roles at AstraZeneca, Dr. Plasterer has been responsible for establishing and executing the FAIR data strategy which includes knowledge representation, vocabulary & metadata services, semantic visualization, analytics and business case development. This strategy has been deployed to build the competitive intelligence and integrative informatics frameworks for R&D. Tom also serves on the Pistoia Alliance FAIR data advisory board.
University of Texas at Austin
Dr. Ying Ding is Bill & Lewis Suit Professor at School of Information, University of Texas at Austin. Before that, she was a professor and director of graduate studies for data science program at School of Informatics, Computing, and Engineering at Indiana University. She has led the effort to develop the online data science graduate program for Indiana University. She also worked as a senior researcher at Department of Computer Science, University of Innsburck (Austria) and Free University of Amsterdam (the Netherlands). She has been involved in various NIH, NSF and European-Union funded projects. She has published 240+ papers in journals, conferences, and workshops, and served as the program committee member for 200+ international conferences. She is the co-editor of book series called Semantic Web Synthesis by Morgan & Claypool publisher, the co-editor-in-chief for Data Intelligence published by MIT Press and Chinese Academy of Sciences, and serves as the editorial board member for several top journals in Information Science and Semantic Web. She is the co-founder of Data2Discovery company advancing cutting edge AI technologies in drug discovery and healthcare. Her current research interests include data-driven science of science, AI in healthcare, Semantic Web, knowledge graph, data science, scholarly communication, and the application of Web technologies.